Senior Director, Inspection Readiness at Absci

Job description

About Absci Absci is a clinical-stage biotechnology company advancing novel therapeutics using generative AI. Our Integrated Drug Creation™ platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci is a global company headquartered in Vancouver, WA, and maintains offices in New York City, Switzerland, and Serbia. Learn more at www.absci.com or follow us on LinkedIn (@absci), X (@Abscibio), and YouTube. The Senior Director, Inspection Readiness leader is a senior, hybrid Clinical Operations professional who provides Sponsor-level leadership for inspection readiness, GCP compliance, and clinical trial operational excellence across Absci’s clinical development portfolio. This individual will work across studies and functions to ensure that clinical trial processes, documentation, oversight, systems, and study conduct are maintained in a state of inspection readiness and can withstand regulatory inspection. A critical responsibility of this role is to bring a cross-functional Sponsor perspective to inspection readiness. The leader will proactively identify operational and compliance gaps, assess their potential impact, establish practical remediation plans, and drive issues to resolution in partnership with Clinical Operations, Quality, Regulatory, Data Management/Biometrics, Clinical Development, Development Services, and other relevant functions. This leader reports directly to the Senior Vice President & Head of Global Clinical Operations and will serve as a senior subject-matter expert and operational partner across the development organization. The role requires the ability to operate strategically while remaining sufficiently hands-on to review processes and documentation, support study teams, and ensure sustained execution of inspection-ready practices. Key Responsibilities • Provide Sponsor-level leadership for inspection readiness and GCP compliance across clinical studies, programs, and relevant functional areas. • Develop, implement, and maintain a risk-based, scalable inspection readiness framework that supports Absci’s evolving clinical development portfolio. • Assess the inspection readiness of clinical studies and operational processes, including documentation quality, Sponsor oversight, issue management, data integrity, and adherence to applicable procedures and regulatory requirements. • Proactively identify compliance, process, documentation, and oversight gaps; evaluate risk and potential regulatory impact; and partner with accountable functions to establish, track, and complete remediation and preventive actions. • Provide cross-functional Sponsor oversight and coordination of clinical trial registration and results-reporting requirements, including ClinicalTrials.gov and other applicable public disclosure obligations, in partnership with Regulatory, Clinical Development, Biostatistics/Data Management, and other stakeholders. • Establish and oversee processes for tracking applicable reporting requirements, accountabilities, timelines, supporting documentation, and evidence of compliance. • Partner with functional leaders to establish, maintain, and periodically assess clinical development training requirements and training matrices, ensuring role-based training is current, documented, and inspection-ready. • Review and assess clinical development SOPs, work instructions, plans, templates, and related controlled documents for clarity, consistency, regulatory alignment, appropriate Sponsor oversight, and operational practicality. • Identify areas where new or revised SOPs, work instructions, standards, tools, or processes are needed and support development, implementation, training, and adoption. • Partner closely with Data Management/Biometrics and other cross-functional teams to support operational quality, data integrity, inspection readiness, issue resolution, and readiness for key stu